{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:49:40Z","timestamp":1790178580048,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"publisher","award":["DAMAS 1499\/2019 and 2020"],"award-info":[{"award-number":["DAMAS 1499\/2019 and 2020"]}],"id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012521","name":"Universitas Gadjah Mada","doi-asserted-by":"publisher","award":["RTA 133\/2607-2020"],"award-info":[{"award-number":["RTA 133\/2607-2020"]}],"id":[{"id":"10.13039\/501100012521","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NUS-UGM-Tahir Foundation","award":["1\/2018 and 1\/2020"],"award-info":[{"award-number":["1\/2018 and 1\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>More than one third of breast cancer patients including those that are diagnosed in early stages will develop distant metastasis. Patterns of distant metastasis and the associated risks according to the molecular subtypes are not completely revealed particularly in populations of patients with delayed diagnosis and advanced stages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Breast cancer patients (<jats:italic>n<\/jats:italic>= 1304) admitted to our institute (2014\u20132017) were evaluated to identify the metastatic patterns and the associated risks. Metastatic breast cancers at diagnosis were found in 245 patients (18.7%), and 1059 patients were then grouped into non-metastatic and metastatic groups after a median follow-up of 3.8\u2009years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Infiltration of the tumor to the skin and chest wall prevailed as the most powerful predictor for distant metastasis (OR 2.115, 95% CI 1.544\u20132.898) particularly in the luminal A-like subtype (OR 2.685, 95% CI 1.649\u20134.371). Nodal involvement was also significantly associated with the risk of distant metastasis (OR 1.855, 95% CI 1.319\u20132.611), and the risk was higher in the Luminal A-like subtype (OR 2.572, 95% CI 1.547\u20134.278). Luminal A-like subtype had a significant higher risk of bone metastasis (OR 1.601, 95% CI 1.106\u20132.358). In respect to treatment, a combination of anthracyclines and taxanes-based chemotherapy was significantly associated with lower distant organ spread in comparison with anthracycline-based chemotherapy (OR 0.510, 95% CI 0.355\u20130.766) and the effect was stronger in Luminal A-like subtype (OR 0.417, 95% CI 0.226\u20130.769). Classification into Luminal and non-Luminal subtypes revealed significant higher risks of bone metastasis in the Luminal subtype (OR 1.793, 95% CI 1.209\u20132.660) and pulmonary metastasis in non-Luminal breast cancer (OR 1.445, 95% CI 1.003\u20132.083).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In addition to guiding the treatment plan, a comprehensive analysis of clinicopathological variables including the molecular subtypes could assist in the determination of distant metastasis risks of breast cancer patients. Our study offers new perspectives concerning the risks of distant metastasis in breast cancer subtypes in order to plan intensive surveillance or escalation of treatment particularly in a setting where patients are predominantly diagnosed in late stages.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12957-020-01893-w","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T15:02:33Z","timestamp":1590850953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2607-6682","authenticated-orcid":false,"given":"Sumadi Lukman","family":"Anwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widya Surya","family":"Avanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Cahyo","family":"Nugroho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Choridah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ery Kus","family":"Dwianingsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirsma Arif","family":"Harahap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teguh","family":"Aryandono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahyu","family":"Wulaningsih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"issue":"6","key":"1893_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin."},{"key":"1893_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.17.00207","volume":"4","author":"M Bellanger","year":"2018","unstructured":"Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Glob Oncol. 2018;4:1\u201316. https:\/\/doi.org\/10.1200\/JGO.17.00207.","journal-title":"J Glob Oncol."},{"key":"1893_CR3","doi-asserted-by":"publisher","unstructured":"Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries. Breast Cancer (Auckl). 2018;12: 1178223417752677. doi:https:\/\/doi.org\/10.1177\/1178223417752677.","DOI":"10.1177\/1178223417752677"},{"issue":"10","key":"1893_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/PHM.0000000000000982","volume":"97","author":"SL Anwar","year":"2018","unstructured":"Anwar SL, Adistyawan G, Wulaningsih W, Gutenbrunner C, Nugraha B. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in low- and middle income countries. Am J Phys Med Rehabil. 2018;97(10):764\u201371. https:\/\/doi.org\/10.1097\/PHM.0000000000000982.","journal-title":"Am J Phys Med Rehabil."},{"issue":"6024","key":"1893_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559\u201364. https:\/\/doi.org\/10.1126\/science.1203543.","journal-title":"Science."},{"issue":"12","key":"1893_CR6","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574\u20136. https:\/\/doi.org\/10.1002\/cam4.2474.","journal-title":"Cancer Med."},{"issue":"9472","key":"1893_CR7","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"O Abe","year":"2005","unstructured":"Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687\u2013717. https:\/\/doi.org\/10.1016\/S0140-6736(05)66544-0.","journal-title":"Lancet."},{"issue":"6797","key":"1893_CR8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rile T, Eisen MB, Van De Rijn M, Jeffrey SS, Ress CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352. https:\/\/doi.org\/10.1038\/35021093.","journal-title":"Nature."},{"issue":"7418","key":"1893_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature."},{"issue":"8","key":"1893_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol."},{"key":"1893_CR11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Th\u00fcrlimann B, Panel HS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206\u201323. https:\/\/doi.org\/10.1093\/annonc\/mdt303.","journal-title":"Ann Oncol."},{"issue":"20","key":"1893_CR12","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20137. https:\/\/doi.org\/10.1200\/JCO.2009.25.9820.","journal-title":"J Clin Oncol."},{"issue":"14","key":"1893_CR13","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1001\/jama.295.14.1658","volume":"295","author":"DA Berry","year":"2006","unstructured":"Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. J Am Med Assoc. 2006;295(14):1658\u201367. https:\/\/doi.org\/10.1001\/jama.295.14.1658.","journal-title":"J Am Med Assoc."},{"issue":"5","key":"1893_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ijc.22892","volume":"122","author":"N Bentzon","year":"2008","unstructured":"Bentzon N, D\u00fcring M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer. 2008;122(5):1089\u201394. https:\/\/doi.org\/10.1002\/ijc.22892.","journal-title":"Int J Cancer."},{"issue":"6","key":"1893_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AHCC cancer staging maual and future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134. https:\/\/doi.org\/10.1245\/s10434-010-0985-4.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"1893_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000350774","volume":"8","author":"HP Sinn","year":"2013","unstructured":"Sinn HP, Kreipe H. A brief overview of the WHO classification of breast tumors, 4th edition, focusing on issues and updates from the 3rd edition. Breast Care. 2013;8(2):149\u201354. https:\/\/doi.org\/10.1159\/000350774.","journal-title":"Breast Care."},{"key":"1893_CR17","first-page":"571","volume":"18","author":"C Genestie","year":"1998","unstructured":"Genestie C, Zafrani B, Asselain B, Fourquet A, Rozan S, Validire P, et al. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res. 1998;18:571\u20136.","journal-title":"Anticancer Res."},{"key":"1893_CR18","doi-asserted-by":"publisher","unstructured":"Widodo I, Dwianingsih EK, Anwar SL, Triningsih FE, Utoro T, Aryandono T, et al. Prognostic value of clinicopathological factors for Indonesian breast carcinomas of different molecular subtypes. Asian Pacific J Cancer Prev. 2017;18(5):1251-6. doi: https:\/\/doi.org\/10.22034\/APJCP.2017.18.5.1251.","DOI":"10.22034\/APJCP.2017.18.5.1251"},{"issue":"3","key":"1893_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-015-3572-3","volume":"153","author":"EC Inwald","year":"2015","unstructured":"Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofst\u00e4dter F, Gerstenhauer M, et al. 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival. Breast Cancer Res Treat. 2015;153(3):647\u201358. https:\/\/doi.org\/10.1007\/s10549-015-3572-3.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"1893_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding SA. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438\u201351. https:\/\/doi.org\/10.3322\/caac.21583.","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"1893_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000441818","volume":"10","author":"L Fan","year":"2015","unstructured":"Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in Asia. Breast Care. 2015;10(6):372\u20138. https:\/\/doi.org\/10.1159\/000441818.","journal-title":"Breast Care."},{"issue":"2","key":"1893_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10549-008-0303-z","volume":"117","author":"L Fan","year":"2009","unstructured":"Fan L, Zheng Y, Da Yu K, Liu GY, Wu J, Lu JS, et al. Breast cancer in a transitional society over 18\u2009years: trends and present status in Shanghai, China. Breast Cancer Res Treat. 2009;117(2):409\u201316. https:\/\/doi.org\/10.1007\/s10549-008-0303-z.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"1893_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-018-4125-z","volume":"18","author":"SL Anwar","year":"2018","unstructured":"Anwar SL, Tampubolon G, Van Hemelrijck M, Hutajulu SH, Watkins J, Wulaningsih W. Determinants of cancer screening awareness and participation among Indonesian women. BMC Cancer. 2018;18(1):208. https:\/\/doi.org\/10.1186\/s12885-018-4125-z.","journal-title":"BMC Cancer."},{"issue":"1","key":"1893_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13058-019-1174-4","volume":"21","author":"M Foerster","year":"2019","unstructured":"Foerster M, Anderson BO, McKenzie F, Galukande M, Anele A, Adisa C, et al. Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study. Breast Cancer Res. 2019;21(1):93. https:\/\/doi.org\/10.1186\/s13058-019-1174-4.","journal-title":"Breast Cancer Res."},{"key":"1893_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/eurpub\/ckv233","volume":"26","author":"M Orsini","year":"2016","unstructured":"Orsini M, Tretarre B, Daur\u00e8s JP, Bessaoud F. Individual socioeconomic status and breast cancer diagnostic stages: a French case-control study. Eur J Public Health. 2016;26:445\u201350. https:\/\/doi.org\/10.1093\/eurpub\/ckv233.","journal-title":"Eur J Public Health."},{"key":"1893_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12957-015-0632-4","volume":"13","author":"M Galukande","year":"2015","unstructured":"Galukande M, Wabinga H, Mirembe F. Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study. World J Surg Oncol. 2015;13:220. https:\/\/doi.org\/10.1186\/s12957-015-0632-4.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"1893_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12905-019-0724-3","volume":"19","author":"SL Anwar","year":"2019","unstructured":"Anwar SL, Raharjo CA, Herviastuti R, Dwianingsih EK, Setyoheriyanto D, Avanti WS, et al. Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study. BMC Womens Health. 2019;19(1):28. https:\/\/doi.org\/10.1186\/s12905-019-0724-3.","journal-title":"BMC Womens Health."},{"key":"1893_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amsu.2020.02.010","volume":"52","author":"SL Anwar","year":"2020","unstructured":"Anwar SL, Dwianingsih EK, Avanti WS, Choridah L, Suwardjo, Aryandono T. Aggressive behavior of Her-2 positive colloid breast carcinoma: a case report in a metastatic breast cancer. Ann Med Surg. 2020;52:48\u201352. https:\/\/doi.org\/10.1016\/j.amsu.2020.02.010.","journal-title":"Ann Med Surg"},{"key":"1893_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-018-1033-8","volume":"20","author":"M Abubakar","year":"2018","unstructured":"Abubakar M, Sung H, Bcr D, Guida J, Tang TS, Pfeiffer RM, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018;20:1\u201314. https:\/\/doi.org\/10.1186\/s13058-018-1033-8.","journal-title":"Breast Cancer Res"},{"key":"1893_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5710-5","volume":"19","author":"B Holleczek","year":"2019","unstructured":"Holleczek B, Stegmaier C, Radosa JC, Solomayer EF, Brenner H. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis: results from a registry-based study from Germany. BMC Cancer. 2019;19:1\u201314. https:\/\/doi.org\/10.1186\/s12885-019-5710-5.","journal-title":"BMC Cancer"},{"issue":"10","key":"1893_CR31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.ejca.2014.04.002","volume":"50","author":"A Purushotham","year":"2014","unstructured":"Purushotham A, Shamil E, Cariati M, Agbaje O, Muhidin A, Gillett C, et al. Age at diagnosis and distant metastasis in breast cancer: a surprising inverse relationship. Eur J Cancer. 2014;50(10):1697\u2013705. https:\/\/doi.org\/10.1016\/j.ejca.2014.04.002.","journal-title":"Eur J Cancer."},{"key":"1893_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1477-7819-12-230","volume":"12","author":"TT Sio","year":"2014","unstructured":"Sio TT, Chang K, Jayakrishnan R, Wu D, Politi M, Malacarne D, et al. Patient age is related to decision-making, treatment selection, and perceived quality of life in breast cancer survivors. World J Surg Oncol. 2014;12:230. https:\/\/doi.org\/10.1186\/1477-7819-12-230.","journal-title":"World J Surg Oncol."},{"key":"1893_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.23736\/S1973-9087.18.04843-8","volume":"55","author":"SL Anwar","year":"2019","unstructured":"Anwar SL, Adistya Adistyawan G, Wulaningsih W, Erlangga Z, Gut Enbrunner C, Nugraha B. Cancer rehabilitation: closing the gap in low- and middle-income countries. Eur J Phys Rehabil Med. 2019;55:536\u20138. https:\/\/doi.org\/10.23736\/S1973-9087.18.04843-8.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"3","key":"1893_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","volume":"49","author":"Y Gao","year":"2019","unstructured":"Gao Y, Bado I, Wang H, Zhang W, Rosen JM, Zhang XHF. Metastasis organotropism: redefining the congenial soil. Dev. Cell. 2019;49(3):375\u201391. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.012.","journal-title":"Dev. Cell."},{"issue":"6","key":"1893_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/cncr.21285","volume":"104","author":"EB Elkin","year":"2005","unstructured":"Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer. 2005;104(6):1149\u201357. https:\/\/doi.org\/10.1002\/cncr.21285.","journal-title":"Cancer."},{"issue":"11","key":"1893_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/j.1445-2197.2006.03918.x","volume":"76","author":"S Laura","year":"2006","unstructured":"Laura S, Coombs NJ, Ung O, Boyages J. Tumour size as a predictor of axillary node metastases in patients with breast cancer. ANZ J Surg. 2006;76(11):1002\u20136. https:\/\/doi.org\/10.1111\/j.1445-2197.2006.03918.x.","journal-title":"ANZ J Surg."},{"key":"1893_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1186\/s12885-019-5941-5","volume":"19","author":"Y Qiu","year":"2019","unstructured":"Qiu Y, Wang L, Zhong X, Li L, Chen F, Xiao L, et al. A multiple breast cancer stem cell model to predict recurrence of T1-3, N0 breast cancer. BMC Cancer. 2019;19:729. https:\/\/doi.org\/10.1186\/s12885-019-5941-5.","journal-title":"BMC Cancer."},{"issue":"9","key":"1893_CR38","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/cncr.21394","volume":"104","author":"U Guth","year":"2005","unstructured":"Guth U, Wight E, Schotzau A, Langer I, Dieterich H, Rochlitz C, et al. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification. Cancer. 2005;104(9):1862\u201370. https:\/\/doi.org\/10.1002\/cncr.21394.","journal-title":"Cancer."},{"issue":"3","key":"1893_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jamcollsurg.2014.04.003","volume":"219","author":"D Silverman","year":"2014","unstructured":"Silverman D, Ruth K, Sigurdson ER, Egleston BL, Goldstein LJ, Wong YN, et al. Skin involvement and breast cancer: are T4b lesions of all sizes created equal? J Am Coll Surg. 2014;219(3):354\u2013544. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.04.003.","journal-title":"J Am Coll Surg."},{"issue":"8","key":"1893_CR40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/000313480407000802","volume":"70","author":"GV Poole","year":"2004","unstructured":"Poole GV, Thigpen JT, Vance RB, Barber WH. Management of women who present with T4 breast cancer. Am Surg. 2004;70(8):662\u20136.","journal-title":"Am Surg."},{"key":"1893_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12885-016-2100-0","volume":"16","author":"SEP Joosten","year":"2016","unstructured":"Joosten SEP, Ret\u00e8l VP, Coup\u00e9 VMH, van den Heuvel MM, van Harten WH. Scenario drafting for early technology assessment of next generation sequencing in clinical oncology. BMC Cancer. 2016;16:166. https:\/\/doi.org\/10.1186\/s12885-016-2100-0.","journal-title":"BMC Cancer."},{"issue":"9","key":"1893_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184680","volume":"12","author":"OC Buonomo","year":"2017","unstructured":"Buonomo OC, Caredda E, Portarena I, Vanni G, Orlandi A, Bagni C, et al. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes. PLoS One. 2017;12(9):e0184680. https:\/\/doi.org\/10.1371\/journal.pone.0184680.","journal-title":"PLoS One."},{"issue":"6","key":"1893_CR43","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190288","volume":"39","author":"Y Yao","year":"2019","unstructured":"Yao Y, Chu Y, Xu B, Hu Q, Song Q. Risk factors for distant metastasis of patients with primary triple-negative breast cancer. Biosci Rep. 2019;39(6):BSR20190288. https:\/\/doi.org\/10.1042\/BSR20190288.","journal-title":"Biosci Rep."},{"issue":"6","key":"1893_CR44","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/annonc\/mdu11","volume":"25","author":"H Bonnefoi","year":"2014","unstructured":"Bonnefoi H, Liti\u00e8re S, Piccart M, MacGrogan G, Fumoleau P, Brain E, et al. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994\/BIG 1-00 phase III trial. Ann Oncol. 2014;25(6):1128\u201336. https:\/\/doi.org\/10.1093\/annonc\/mdu11.","journal-title":"Ann Oncol."},{"issue":"2","key":"1893_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1804710.","journal-title":"N Engl J Med."},{"issue":"16","key":"1893_CR46","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1158\/1078-0432.CCR-12-0286","volume":"18","author":"SK Chia","year":"2012","unstructured":"Chia SK, Bramwell VH, Tu D, Shepherd LE, Jiang S, Vickery T, et al. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen. Clin Cancer Res. 2012;18(16):4465\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0286.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"1893_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","volume":"11","author":"KS Albain","year":"2010","unstructured":"Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010;11(1):55\u201365. https:\/\/doi.org\/10.1016\/S1470-2045(09)70314-6.","journal-title":"Lancet Oncol."},{"issue":"3","key":"1893_CR48","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24(3):3764\u201334. https:\/\/doi.org\/10.1200\/JCO.2005.04.7985.","journal-title":"J Clin Oncol."},{"issue":"7","key":"1893_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218434","volume":"14","author":"D Herr","year":"2019","unstructured":"Herr D, Wischnewsky M, Joukhadar R, Chow O, Janni W, Leinert E, et al. Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer?: a retrospective multicenter study. PLoS One. 2019;14(7):e0218434. https:\/\/doi.org\/10.1371\/journal.pone.0218434.","journal-title":"PLoS One."},{"issue":"9814","key":"1893_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"K Albain","year":"2012","unstructured":"Albain K, Anderson S, Arriagada R, Barlow W, Bergh J, Bliss J, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcomes among 100,000 women in 123 randomised trials. Lancet. 2012;379(9814):432\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(11)61625-5.","journal-title":"Lancet."},{"key":"1893_CR51","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1477-7819-12-344","volume":"12","author":"K Kontani","year":"2014","unstructured":"Kontani K, Hashimoto SI, Murazawa C, Norimura S, Tanaka H, Ohtani M, et al. Factors responsible for long-term survival in metastatic breast cancer. World J Surg Oncol. 2014;12:344. https:\/\/doi.org\/10.1186\/1477-7819-12-344.","journal-title":"World J Surg Oncol."},{"issue":"1","key":"1893_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12885-018-4371-0","volume":"18","author":"J Jin","year":"2018","unstructured":"Jin J, Gao Y, Zhang J, Wang L, Wang B, Cao J, et al. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple-negative breast cancer. BMC Cancer. 2018;18(1):446. https:\/\/doi.org\/10.1186\/s12885-018-4371-0.","journal-title":"BMC Cancer."},{"issue":"10","key":"1893_CR53","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384047.2018.145659","volume":"19","author":"L Jin","year":"2018","unstructured":"Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: molecular biology and therapeutic implications. Cancer Biol. Ther. 2018;19(10):858\u201368. https:\/\/doi.org\/10.1080\/15384047.2018.145659.","journal-title":"Cancer Biol. Ther."},{"key":"1893_CR54","doi-asserted-by":"publisher","unstructured":"Sihto H, Lundin J, Lundin M, Lehtim\u00e4ki T, Ristim\u00e4ki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res. 2011;13(5):R87. oi: https:\/\/doi.org\/10.1186\/bcr2944.","DOI":"10.1186\/bcr2944"},{"issue":"3","key":"1893_CR55","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00428-017-2065-7","volume":"470","author":"IA Moln\u00e1r","year":"2017","unstructured":"Moln\u00e1r IA, Moln\u00e1r B\u00c1, V\u00edzkeleti L, Fekete K, Tam\u00e1s J, De\u00e1k P, et al. Breast carcinoma subtypes show different patterns of metastatic behavior. Virchows Arch. 2017;470(3):275\u201383. https:\/\/doi.org\/10.1007\/s00428-017-2065-7.","journal-title":"Virchows Arch."},{"key":"1893_CR56","doi-asserted-by":"publisher","first-page":"9254","DOI":"10.1038\/s41598-017-10166-8","volume":"7","author":"MT Chen","year":"2017","unstructured":"Chen MT, Sun HF, Zhao Y, Fu WY, Yang LP, Gao SP, et al. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep. 2017;7:9254. https:\/\/doi.org\/10.1038\/s41598-017-10166-8.","journal-title":"Sci Rep."},{"issue":"1","key":"1893_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-018-0047-0","volume":"2","author":"W Chen","year":"2018","unstructured":"Chen W, Hoffmann AD, Liu H, Liu X. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precis Oncol. 2018;2(1):4. https:\/\/doi.org\/10.1038\/s41698-018-0047-0.","journal-title":"NPJ Precis Oncol."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01893-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01893-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01893-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T18:41:44Z","timestamp":1696185704000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01893-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01893-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have declared no potential competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study has been conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants. The study protocol has been approved by the Medical and Health Research Ethics Committee Faculty of Medicine, Public Health, and Nursing\u2014Universitas Gadjah Mada Yogyakarta (1143\/EC\/2017 and 1049\/EC\/2018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their consent for publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"117"}}